CN Patent
CN1072172A — 新颖的7-取代-9-取代氨基-6-去甲基-6-去氧四环素
Assigned to Wyeth Holdings LLC · Expires 1993-05-19 · 33y expired
What this patent protects
本发明揭示了具有广谱抗微生物活性,包括对四 环素类耐药的微生物的新颖的7-取代-9-取代氨基 -6-去甲基-6-去氧四环素类化合物,也揭示了用于 制备本发明的新颖化合物的中间体和制备方法。
USPTO Abstract
本发明揭示了具有广谱抗微生物活性,包括对四 环素类耐药的微生物的新颖的7-取代-9-取代氨基 -6-去甲基-6-去氧四环素类化合物,也揭示了用于 制备本发明的新颖化合物的中间体和制备方法。
Drugs covered by this patent
- Xerava (ERAVACYCLINE DIHYDROCHLORIDE) · Tetraphase Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.